Familial autoimmunity and risk of developing immune thrombocytopenia and Evans syndrome
Pediatric Blood & Cancer · 2024
DOI: 10.1002/pbc.31239 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pediatric Blood & Cancer, 2024. Verfasst von Michell M Lozano Chinga und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Allergy and Immunology, Phoenix Children's Hospital, Phoenix, Arizona, USA. Hauptthemen laut MEDLINE: Anemia, Hemolytic, Autoimmune, Purpura, Thrombocytopenic, Idiopathic, Autoimmunity, Thrombocytopenia. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 38 Literaturangaben. Gefördert von: NCATS NIH HHS, University of Utah.
Abstract (Originalsprache)
Background
Immune thrombocytopenia (ITP) and Evans syndrome (ES) are manifestations of immune dysregulation. Genetic variants in immune‐related genes have been identified in patients with ITP and especially ES. We aimed to explore familial autoimmunity in patients with ITP and ES to understand possible contributions to chronicity. Procedure We assessed family history in two ways: via patient report for ITP and ES and by population‐based analysis using the Utah Population Database (UPDB) for ITP. A total of 266 patients with ITP and 21 patients with ES were identified via chart review, and 252 of the 266 patients with ITP were also identified in the UPDB.
Results
Chart review showed familial autoimmunity in 29/182 (15.9%) and 25/84 (29.8%) of patients with newly diagnosed+persistent (nd+p) ITP and chronic ITP (cITP), respectively, ( p = .009). The UPDB analysis revealed that autoimmunity in relatives of patients with nd+pITP was higher than in relatives of controls (odds ratio [OR]: 1.69 [1.19–2.41], p = .004), but was not significantly increased in relatives of patients with cITP (OR 1.10 [0.63–1.92], p = .734). Incomplete family history in medical records likely contributed to the observed discrepancy.
Conclusions
The findings suggest that familial autoimmunity may have a stronger association with the development of ITP rather than its duration. Twelve (57.1%) patients with ES reported autoimmunity in their relatives. UPDB analysis was omitted due to the small number of patients with ES. The use of population databases offers a unique opportunity to assess familial health and may provide clues about contributors to immune dysregulation features within families.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Allergy and Immunology, Phoenix Children's Hospital, Phoenix, Arizona, USA.
- Department of Child Health, University of Arizona College of Medicine, Phoenix, Arizona, USA.
- Department of Pediatrics, Creighton University, Phoenix, Arizona, USA.
- Department of Medicine, Mayo Clinic College of Medicine and Science, Scottsdale, Arizona, USA.
- Weill Cornell Medical School, New York, New York, USA.
- Seattle Children's Cancer and Blood Disorders Center, Seattle Children's Hospital, Seattle, Washington, USA.
ORCID-Profile: Michell M Lozano Chinga, James B Bussel, Huong Meeks, Jessica A Meznarich
Förderung
- NCATS NIH HHS
- University of Utah
Zitieren
APA
Lozano Chinga, M. M., Bussel, J. B., Fluchel, M. N., Wilkes, J., Zhang, C., Meeks, H., & Meznarich, J. A. (2024). Familial autoimmunity and risk of developing immune thrombocytopenia and Evans syndrome. Pediatric Blood & Cancer. https://doi.org/10.1002/pbc.31239
Vancouver
Lozano Chinga MM, Bussel JB, Fluchel MN, Wilkes J, Zhang C, Meeks H, et al. Familial autoimmunity and risk of developing immune thrombocytopenia and Evans syndrome. Pediatric Blood & Cancer. 2024. doi:10.1002/pbc.31239
BibTeX
@article{LozanoChinga2024,
author = {Lozano Chinga, Michell M and Bussel, James B and Fluchel, Mark N and Wilkes, Jacob and Zhang, Chong and Meeks, Huong and Meznarich, Jessica A},
title = {Familial autoimmunity and risk of developing immune thrombocytopenia and Evans syndrome},
journal = {Pediatric Blood & Cancer},
year = {2024},
doi = {10.1002/pbc.31239}
}
EUVIMED